| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Omniab, Inc. (OABI) has 6 insiders with recent SEC Form 4 filings, including 7 buys and 0 sells. OABI is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 4.38M | $10.15M | - | |
| Dir | 2.93M | $6.80M | - | |
| Other | 383.6K | $890.0K | - | |
| CFO | 259.4K | $601.8K | - | |
| Dir | 93.3K | $216.5K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov 30, 2022 | Foehr Matthew W72 | President &CEO | Buy | 300,000 | $3.39 | $1,016,340.00 | +21.3% | +17.8% | +24.0% | |
| Nov 28, 2022 | Gustafson Kurt A81 | EVP, Finance And CFO | Buy | 10,000 | $2.81 | $28,100.00 | +6.2% | +38.5% | +46.9% | |
| Nov 11, 2022 | Cochran Jennifer R.66 | Director | Buy | 30,000 | $3.10 | $92,928.00 | +118.9% | +35.6% | +43.7% | |
| Nov 10, 2022 | Boyce Sarah | Director | Buy | 36,000 | $2.82 | $101,396.70 | +171.4% | +31.8% | +40.4% | |
| Nov 9, 2022 | Foehr Matthew W72 | President &CEO | Buy | 100,000 | $2.76 | $276,160.00 | +7.7% | +45.7% | +58.0% | |
| Nov 9, 2022 | Patel Sunil | Director | Buy | 43,000 | $2.77 | $119,110.00 | +24.9% | +45.7% | +58.0% |